NCT00861965View on ClinicalTrials.gov

Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

April 30, 2011

Conditions
Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma
Interventions
BIOLOGICAL

AlloStim-8

intravenous infusion of mis-matched AlloStim-8

BIOLOGICAL

AlloStim-8

intravenous infusion of AlloStim-8 on day 7

BIOLOGICAL

AlloStim-8

intravenous infusion of AlloStim-8 on day 14

BIOLOGICAL

AlloStim-8

intravenous infusion of AlloStim-8 on day 21

Trial Locations (1)

92010

Immunovative Clinical Research, Inc, Carlsbad

Sponsors
All Listed Sponsors
lead

Mirror Biologics, Inc.

INDUSTRY

NCT00861965 - Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers | Biotech Hunter | Biotech Hunter